These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18794592)

  • 41. Multimodal therapy for vertebral involvement of systemic mastocytosis.
    Krüger A; Hamann C; Brendel C; Ramaswamy A; Schnabel M; Neubauer A; Hofbauer LC
    Spine (Phila Pa 1976); 2009 Aug; 34(17):E626-8. PubMed ID: 19644322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colon cancer surveillance in inflammatory bowel disease patients: current and emerging practices.
    Velayos F
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):817-25. PubMed ID: 19090741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone disease in the inflammatory bowel disease population.
    Smith J; Lidofsky S
    Med Health R I; 2009 Apr; 92(4):125-7. PubMed ID: 19452755
    [No Abstract]   [Full Text] [Related]  

  • 44. Colorectal adenomas in patients presenting with inflammatory bowel disease.
    Loffeld RJ
    Neth J Med; 2009 Jan; 67(1):21-4. PubMed ID: 19155543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Superior mesenteric vein thrombosis after bowel resection in patients with inflammatory bowel disease.
    McCutcheon T
    Gastroenterol Nurs; 2009; 32(2):85-91; quiz 92-3. PubMed ID: 19357471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical study of the relationship between inflammatory bowel diseases and colorectal neoplasms.
    Zhao YJ; Yuan YZ
    J Dig Dis; 2009 May; 10(2):113-7. PubMed ID: 19426393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease.
    Marks DJ; Miyagi K; Rahman FZ; Novelli M; Bloom SL; Segal AW
    Am J Gastroenterol; 2009 Jan; 104(1):117-24. PubMed ID: 19098859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
    Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
    Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dermatological signs during inflammatory bowel diseases.
    Feliciani C; De Simone C; Amerio P
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():15-21. PubMed ID: 19530507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Skin manifestations of pediatric inflammatory bowel disease].
    Martín de Carpi J; Chávez Caraza K; Vicente Villa MA; González Enseñat MA; Vilar Escrigas P; Vila Miravet V; Guallarte Alias P; Varea Calderón V
    An Pediatr (Barc); 2009 Jun; 70(6):570-7. PubMed ID: 19446510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone and fat interplay in inflammatory bowel disease: clinical implications and future perspectives.
    Polyzos SA; Kountouras J
    Inflamm Bowel Dis; 2014 Nov; 20(11):E22. PubMed ID: 25230168
    [No Abstract]   [Full Text] [Related]  

  • 52. Understanding why probiotic therapies can be effective in treating IBD.
    Fedorak RN
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increase in vertebral fracture risk in postmenopausal women using omeprazole.
    Roux C; Briot K; Gossec L; Kolta S; Blenk T; Felsenberg D; Reid DM; Eastell R; Glüer CC
    Calcif Tissue Int; 2009 Jan; 84(1):13-9. PubMed ID: 19023510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Osteoporosis in patients with systemic lupus erythematosus.
    García-Carrasco M; Mendoza-Pinto C; Escárcega RO; Jiménez-Hernández M; Etchegaray Morales I; Munguía Realpozo P; Rebollo-Vázquez J; Soto-Vega E; Delezé M; Cervera R
    Isr Med Assoc J; 2009 Aug; 11(8):486-91. PubMed ID: 19891237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The efficacy of strontium ranelate (Osseor) on fractures in osteoporosis].
    Novak S
    Reumatizam; 2008; 55(2):75-7. PubMed ID: 19024282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Carbonyl groups content in serum proteins as an indicator of disease activity in children with inflammatory bowel diseases and its dependence on the other markers of inflammatory process].
    Krzesiek E; Pytrus T; Kosmowska A; Iwańczak B
    Pol Merkur Lekarski; 2008 Dec; 25(150):455-9. PubMed ID: 19205373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specifying the risk of arterial thrombosis in inflammatory bowel disease.
    Chen J; Stone CD
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1061-2; author reply 1062. PubMed ID: 18619916
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of perianal pathology in inflammatory bowel disease.
    van der Sluis RF; Lubbers EJ
    Neth J Med; 1989 Jun; 35 Suppl 1():S50-3. PubMed ID: 2702313
    [No Abstract]   [Full Text] [Related]  

  • 60. Unraveling the mechanisms of thrombosis in inflammatory bowel disease.
    Koutroubakis IE
    Am J Gastroenterol; 2001 May; 96(5):1325-7. PubMed ID: 11374663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.